Bruhn is the former Head of Nestlé Health Science Asia, Oceania, Middle East, and Africa Region.
Hofseth Biocare ASA
Hofseth Biocare ASA has announced the hiring of Paul Bruhn as Head of New Business Development to support the development of the next generation of products targeting clinical nutrition and consumer health.
Previously, Bruhn has worked at Novartis Medical Nutrition and Nestlé Health Science. He has also led businesses in Japan, Korea, India, the Middle East, Singapore, Canada, Switzerland, and Australia, supported by over 25 years of experience in the healthcare and medical nutrition sector.
Regarding his hiring, he expressed: "I am delighted to contribute to the journey of taking HBC to the next level, particularly given the acceleration of business in Asia, China, and across the ANZ region. I believe there is a market need for new clinically backed sources of nutrition, and the specialty ingredients from Hofseth BioCare fill that gap."
Among the most effective bioactive ingredients offered by Hofseth are OmeGo®, ProGo®, NT-II™, and PetGo®, oils that contain all the Omega fatty acids found in fresh whole fish and are 100% natural.
"These ingredients will ensure differentiation in large product categories that are craving for innovation. I look forward to helping put them into leading brands," Bruhn added.
Moreover, Hofseth, Marel, and MMC First Process, in collaboration with Samey Robotics, have designed a new equipment solution that increases grading capacity, provides greater flexibility, and meets Hofseth's sustainability goals.
This new technology includes Marel's dual lane whole fish grading conveyor with integrated AXIN software and a spiral tank for cooling and continuous fish outfeed provided by MMC First Process.
